About 4,000 seriously ill people with C0VID-19 are receiving the drug, as a life-saving alternative, but that drug used for malaria still does not show full results.
In the middle ofto coronavirus crisis facing New York most intensively, where more than 4,758 people and there are 130,689 infected, in the absence of a vaccine or a cure for COVID-19 disease, the state health authorities are treating more than 4,000 patients cWith a medication known as hydroxychloroquine, which could work, although nothing has yet been proven.
Governor Andrew Cuomo He confirmed that in several hospital units in the state is being tested with this drug, used for malaria, to try to save the lives of those patients who are very serious, but warned that there are still no medical studies that can conclude its effectiveness.
“Anecdotally, it has been positive, (the result of the drug) but we need better data before the health system can approve a broader treatment,” he said. the mandatary. “We are doing a test with hydrozocolloquine with Z-Paks in New York State hospitals. “
Cuomo He has said he will do what he can to try to save more lives in New York than those who catch the virus, adding that he is waiting for the federal government to lift a 14-day limit so they can have more supplies.
“We know that the federal government will increase more supplements in the pharmacies and we hope that they will take away the 14-day period because many (patients) are depending on it,” said the political leader, adding that
“It has taken a very short period of time to have a scientific report (…) We do not yet have data from the hospitals or studies (that show their effectiveness) and that will take weeks and even months.”
Eric Wei, vice president and quality director at Health + Hospitals from New York City, assured that this drug is being used, like other treatments to prevent further deaths, while in-depth studies and analyzes are being carried out to look at the real effect.
“In terms of treatments, we are still learning every day about this virus, this terrible disease. We have multiple types of treatments, ongoing studies to see what works best. Many of our patients receive hydroxychloroquine, or Plaquenil, as part of those treatment regimens, “said the official. “But all of this is done with the appropriate type of IRB approval, which is an institutional review board, so we are making sure we follow the science right.”